Clinical Trial

Prevention of Pacemaker Lead Induced Tricuspid regurgitAtion by Transesophageal eCho guidEd Implantation (PLACE)

Name: Prevention of Pacemaker Lead Induced Tricuspid regurgitAtion by Transesophageal eCho guidEd Implantation (PLACE) — clinical trial record (NCT05667519)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PLACE

Recruiting

View on ClinicalTrials.gov →

Summary

This is the first randomized controlled trial comparing transesophageal echocardiography + fluoroscopy guided lead implantation vs. standard lead implantation guided by fluoroscopy only. Patients are randomized 1:1 in the two groups and followed up for up to 3 years.

Trial Details

NCT Number	NCT05667519
Lead Sponsor	LMU Klinikum
Conditions	Tricuspid Regurgitation, Pacemaker Complication
Enrollment	324 participants
Start Date	2022-10-01
Primary Completion	2027-10 (estimated)
Study Completion	2027-10 (estimated)
Updated on ClinicalTrials.gov	2022-12-28